<DOC>
	<DOCNO>NCT01673789</DOCNO>
	<brief_summary>Alopecia Areata ( AA ) one common T cell-mediated autoimmune disease , lead chronic relapse hair loss . The prevalence AA worldwide 0.1 0.2 % , affect estimate 5.3 million people United States . To date , clinical therapy limit disappointed treatment AA . Alternative approach need . Increasing evidence demonstrate stem cell possess function immune modulation . We establish Stem Cell Educator therapy use cord blood-derived multipotent stem cell ( CB-SCs ) ( Zhao Y , et al . BMC Medicine 2012 ) . A closed-loop system circulate patient 's blood blood cell separator , briefly co-cultures patient 's lymphocyte adherent CB-SCs vitro , return educate lymphocyte ( CB-SCs ) patient 's circulation . Our clinical trial reveals single treatment Stem Cell Educator provide lasting reversal autoimmunity allow regeneration islet beta cell improvement metabolic control subject long-standing type 1 diabetes ( T1D ) , another common T cell-mediated autoimmune disorder United States . Here , develop explore therapeutic effectiveness Stem Cell Educator therapy AA patient .</brief_summary>
	<brief_title>Stem Cell Educator Therapy Alopecia Areata</brief_title>
	<detailed_description>A 16-gauge IV needle place leave ( right ) median cubital vein , patient 's blood pass Blood Cell Separator MCS+ ( HaemoneticsÂ® , Braintree , MA ) 35 mL/min 6 7 hour isolate lymphocyte accordance manufacturer 's recommend protocol . The collected lymphocyte transfer device exposure allogeneic CB-SCs ( process control without CB-SCs ) , blood component return patient . After 2 3 hour device , lymphocyte return patient 's circulation via dorsal vein hand gravity flow control ( 2 3 mL/min ) physiological saline . Approximately 10,000 mL blood process procedure result approximately two repeat education lymphocyte fraction . Patients hospitalize two day monitor temperature conduct routine laboratory blood test adverse reaction follow treatment . Follow-up visit schedule 4 , 12 , 24 , 40 , 54 week treatment clinical assessment laboratory test</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Patients screen enrollment study clinical sign laboratory test meet diagnosis standard recommend National Alopecia Areata Foundation ( www.naaf.org ) . Exclusion criterion clinically significant disease liver , kidney , heart . Additional exclusion criterion pregnancy , immunosuppressive medication , viral disease disease associated immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Stem Cell Educator</keyword>
	<keyword>Cord blood stem cell</keyword>
	<keyword>Immune modulation</keyword>
	<keyword>Alopecia Areata</keyword>
</DOC>